![](/cmg-images/logos/FERBER.jpg?v=ac9fc521-fba3-11ec-8ccb-0242156264fe2020)
FERBER & CO. GmbH
Phone: +49 89 41 95 16–0 | Contact: Manfred C. Ferber · Alexander von Hachenburg · [email protected]
www.ferberco.com
Industry Focus
Healthcare, pharma, digital/technology, consumer, retail, industrials, B2B services
Transaction size
€ 25 m – € 500 m
Reference Deals
Selected Transactions: (1) Acquisition of Arkopharma SE by Dermapharm from Montagu Private Equity LLP. (2) Merger of Vitafy Brands and EVP Group. (3) Acquisition of C3-Cannabinoid Compound Company GmbH by Dermapharm from Canopy Growth Corporation. (4) Sale of a majority ownership stake in Dermazentrum in an Owners Buy-out to Halder. (5) USD 40m private placement of Wellster Healthtech. (6) Sale of 75% of teamtechnik Maschinen und Anlagen to Dürr group. (7) Acquisition of Neuraxpharm by Permira from Apax Partners. (8) Acquisition of WindStar Medical GmbH by Oakley Capital from ProSiebenSat.1 majority-owned NuCom group. (9) Sale of Microbeads A/S, a company belonging to EOS Group, to italian Lamberti group.
Industry sectors
Healthcare, pharma, digital/technology, consumer, retail, industrials, B2B services
Profile
FERBER & CO., founded in 1988, is a leading investment banking house
focusing on M&A as well as Corporate Finance for medium-sized transactions
ranging from € 25 million to € 500 million, as well as customized M&A advice from entrepreneurs to entrepreneurs. FERBER & CO. contributes to the success of its customers through its independence, entrepreneurial commitment, sector focus and internationality.
Services
(1) Divestitures and acquisitions, (2) Management buy-outs (MBOs), Management buy-ins (MBIs) and leveraged buy-outs (LBOs), (3) Mergers and joint ventures, (4) Public to Private / Public take-overs, (5) Private placements / Corporate Finance